Ali Bazarbachi - Concepedia

Author

Ali Bazarbachi

Also Known As

A Bazarbachi, A. Bazarbachi, A. bazarbachi, Ali A. Bazarbachi, Ali Bazarbachi, Bazarbachi, A., Bazarbachi, Ali, H de Thé, Juan Pio Torres Carrete, Mohamad Mohty

737

Publications

14K

Citations

H-Index

136

Concepts

All Affiliations

American University of Beirut American University of Beirut Medical Center Inserm Sorbonne Université Centre National de la Recherche Scientifique

About

Ali Bazarbachi is an author at American University of Beirut specializing in medicine, immunology, and hematology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	31	86	4.2K
2	Health Sciences	16	19	1.1K
3	Natural Sciences	3	3	151
4	Public Health	2	2	48
5	Engineering	1	1	37

Ali Bazarbachi

178

Publications

9.2K

Citations

H-Index

Page 1

	Year	Citations
Definition, Prognostic Factors, Treatment, and Response Criteria of Adult T-Cell Leukemia-Lymphoma: A Proposal From an International Consensus Meeting Kunihiro Tsukasaki, Olivier Hermine, Ali Bazarbachi, Journal of Clinical Oncology ImmunologyPathologyImmunotherapyResponse CriteriaHematological Malignancy	2008	546
Revised diagnosis and severity criteria for sinusoidal obstruction syndrome/veno-occlusive disease in adult patients: a new classification from the European Society for Blood and Marrow Transplantation Mohamad Mohty, Florent Malard, Michaël Abécassis, Bone Marrow Transplantation	2016	511
Bone marrow mesenchymal stem cell transplantation in patients with multiple sclerosis: A pilot study Bassem Yamout, Roula Hourani, Haytham I. Salti, Journal of Neuroimmunology Regenerative MedicineCell TherapyTransplantationMarrow TransplantationMedicine	2010	356
Intravitreal Bevacizumab for the Management of Choroidal Neovascularization in Age-related Macular Degeneration Ziad F. Bashshur, Ali Bazarbachi, Alexandre Schakal, American Journal of Ophthalmology Ocular DiseaseVitreous BodyOphthalmologyAge-related DiseasesChoroidal Neovascularization	2006	308
Treatment of Adult T-Cell Leukemia-Lymphoma with Zidovudine and Interferon Alfa Olivier Hermine, Didier Bouscary, Antoine Gessain, New England Journal of Medicine Mixed-phenotype Acute LeukemiaImmunologyPathologyImmune SystemImmunotherapy	1995	268
Revised Adult T-Cell Leukemia-Lymphoma International Consensus Meeting Report Lucy Cook, Shigeo Fuji, Olivier Hermine, Journal of Clinical Oncology	2019	252
Redefining and measuring transplant conditioning intensity in current era: a study in acute myeloid leukemia patients Alexandros Spyridonidis, Myriam Labopin, Bipin N. Savani, Bone Marrow Transplantation Hematological MalignancyTransplantationMixed-phenotype Acute LeukemiaHematologyTransplant Conditioning Intensity	2020	191
Phase 2 study of the efficacy and safety of the combination of arsenic trioxide, interferon alpha, and zidovudine in newly diagnosed chronic adult T-cell leukemia/lymphoma (ATL) Ghada Kchour, Mahdi Tarhini, Hiba El Hajj, Blood	2009	185
Arsenic Trioxide and Interferon- Synergize to Induce Cell Cycle Arrest and Apoptosis in Human T-Cell Lymphotropic Virus Type I–Transformed Cells Ali Bazarbachi, Marwan El‐Sabban, Rihab Nasr, Blood	1999	175
High prevalence of HTLV-I infection in Mashhad, Northeast Iran: A population-based seroepidemiology survey Houshang Rafatpanah, Mohammad Reza Hedayati‐Moghaddam, Farhad Fathimoghadam, Journal of Clinical Virology Virus EpidemiologyHtlv-i InfectionHigh PrevalenceVirologyDisease Outbreak	2011	173

Page 1